Chronic granulomatous disease - Primary phagocytic immunodeficiency

Central-European Journal of Immunology

Volumn 34, Issue 3, 2009, Pages 182-191

  Polańska, Bozena ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Chronic granulomatous disease

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; BCG VACCINE; CASPOFUNGIN; CATALASE; CELL MEMBRANE PROTEIN; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DICLOXACILLIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ITRACONAZOLE; POSACONAZOLE; PREDNISONE; RECOMBINANT GAMMA INTERFERON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SULFONAMIDE; THYMOCYTE ANTIBODY; VORICONAZOLE;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ASPERGILLOSIS; BONE MARROW TRANSPLANTATION; CHEMICAL ANALYSIS; CHRONIC GRANULOMATOUS DISEASE; DEMOGRAPHY; DIAGNOSTIC TEST; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG FEVER; EOSINOPHIL; FLU LIKE SYNDROME; GRAFT VERSUS HOST REACTION; HISTOCHEMISTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IN UTERO STEM CELL TRANSPLANTATION; INJECTION SITE ULCER; LEUKOCYTE ADHESION DEFICIENCY; LYMPHADENOPATHY; MACROPHAGE; MICROORGANISM; MONOCYTE; NEUTROPHIL; NONHUMAN; PRENATAL DIAGNOSIS; REVIEW; SYMPTOMATOLOGY; WEGENER GRANULOMATOSIS; WISKOTT ALDRICH SYNDROME;

EID: 70350596153     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Berendes H, Bridges RA, Good RA (1957): A fatal granulomatosis of childhood: clinical study of a new syndrome. Minn Med 40: 309-312.
2. Baehner RL, Nathan DG (1967): Leukocyte oxidase: a defective activity in chronic granulomatous disease. Science 155: 835-836.
3. Johnston RB Jr, Keele BB Jr, Misra HP et al. (1975): The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. Clin Invest 55: 1357-1372.
4. Quinn MT, Gauss KA (2002): Structure and regulation of neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidase. J Leukoc Biol 76: 760-781.
5. Roos D, de Boer M, Kuribayashi F et al. (1996): Mutation in the X-linked and autosomal recesive forms of chronic granulomatous disease. Blood 87: 1663-1681. (Pubitemid 26068882)
6. Segal BH, Leto TL, Gallin JI et al. (2000): Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79: 170-200. (Pubitemid 30327531)
7. Jurkowska M, Bernatowska E, Bal J (2004): Genetic and biochemical background of chronic granulamatous disease. Arch Immunol Ther Exp (Warsz) 52: 113-120. (Pubitemid 38685051)
8. Heyworth P, Cross A, Curnutte J (2003): Chronic granulomatous disease. Curr Opin Immunol 15: 578-584.
9. Meischl C, Roos D (1998): The molecular basis of chronic granulomatous disease. Springer Semin Immunopathol 19: 417-434. (Pubitemid 28209984)
10. Bionda C, Li XJ, van Bruggen R et al. (2004): Functional analysis of two-amino acid substitutions in gp91phox in a patient with X-linked flavocytochrome b558-positive chronoic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet 115: 418-427.
11. Bu-Ghanim HN, Segal AW, Keep NH, Casimir CM (1995): Molecular analysis in three cases of X91 - variant chronic granulomatous disease. Blood 86: 3575-3582.
12. Stasia MJ, Bordigoni P, Floret D et al. (2005): Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease. Hum Genet 116: 72-82. (Pubitemid 40057918)
13. von Goessel H, Hossle JP, Seger R, Gungor T (2006): Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutation in the CYBB gene. Exp Hematol 34: 528-535.
14. Curnutte JT (1992): Molecular basis of the autosomal recessive forms of chronic granulomatous disease. Immunodefic Rev 3: 149-172.
15. De Silva U, Miller E, Görlach A et al. (2000): Molecular characterization of the mouse p47-phox (Ncf-1) gene and comparative analysis of the mouse p47-phox (Ncf-1) gene to the human NCF1 gene. Mol Cell Biol Res Commun 3: 224-230.
16. Rae J, Noack D, Heyworth PG et al. (2000): Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22(phox). Blood 96: 1106-1112. (Pubitemid 30616880)
17. Patino PJ, Rae J, Noack D et al. (1999): Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox. Blood 94: 2505-2514. (Pubitemid 29467700)
18. Bylund J, Macdonald KL, Brown KL et al. (2007): Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappaB. Eur J Immunol 37: 1087-1096. (Pubitemid 46925344)
19. Dean RT, Nick HP, Schnebli HP (1989): Free radicals inactivate human neutrophil elastase and its inhibitors with comparable efficiency. Biochem Biophys Res Commun 159: 821-827.
20. Tintinger GR, Theron AJ, Steel HC, Anderson R (2001): Accelerated calcium influx and hyperactivation of neutrophils in chronic granulomatous disease. Clin Exp Immunol 123: 254-263.
21. Pegram PS Jr, De Chatelet LR, McCall CE (1978): Comparison of myeloperoxidase activity in leukocyates from normal subjects and patients with chronic granulomatous disease. J Infect Dis 138: 699-702.
22. Lekstrom-Himes JA, Kuhns DB, Alvord WG, Gallin JI (2005): Inhibition of human neutrophil IL-8 production by hydrogen peroxidate and dysregulation in chronic granulomatous disease. J Immunol 174: 411-417.
23. Warris A, Netea MG, Wang JE et al. (2003): Cytokine release in healthy donors and patients with chronic granulomatous disease upon stimulation with Aspergillus fumigatus. Scand J Infect Dis 35: 482-487. (Pubitemid 37138947)
24. Sanford AN, Suriano AR, Herche D et al. (2006): Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus. Rheumatology 45: 178-181. (Pubitemid 43160079)
25. Levine S, Smith VV, Malone M, Sebire NJ (2005): Histopathological features of chronic granulomatous disease (CGD) in childhood. Histopathology 47: 508-516. (Pubitemid 41626729)
26. Dohil M, Prendiville JS, Crawford RI, Speert DP (1997): Cutaneous manifestations of chronic granulomatous disease. Areport of four cases and review of the literature. J Am Acad Dermatol 36: 899-907. (Pubitemid 27265898)
27. Hadfield MG, Ghatak NR, Laine FJ et al. (1991): Brain lesions in chronic granulomatous disease. Acta Neuropathol (Berl) 81: 467-470.
28. Liese JG, Jendrossek V, Jansson A et al. (1996): Chronic granulomatous disease in adults. Lancet 347: 220-223.
29. Winkelstein JA, Marino MC, Johnston RB Jr et al. (2000): Chronic granulomatosus disease. Raport on a national registry of 368 patients. Medicine (Baltimore) 79: 155-169.
30. Mouy R, Fischer A, Vilmer E et al. (1989): Incidence, severity, and preventions in chronic granulomatous disease. J Pediatr 114: 555-560. (Pubitemid 19098285)
31. Córdoba-Guijarro S, Feal C, Daudén E et al. (2000): Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease. J Eur Acad Dermatol Venerol 14: 409-411. (Pubitemid 32898899)
32. Dorman SE, Guide SV, Cinville PS et al. (2002): Nocardia infection in chronic granulomatous disease. Clin Infect Dis 35: 390-394. (Pubitemid 34852568)
33. http://www.esid.org
34. Baehner RL, Nathan DG (1968): Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 278: 971-976.
35. Ochs HD, Igo RP (1973): The NBT slide test: a simple screening method for detecting chronic granulomatous disease and female carriers. J Pediatr 83: 77-82.
36. Repine JE, Rasmussen B, White JG (1979): An improved nitroblue tetrazolium test using phorbol myristate acetate-coated coverslips. Am J Clin Pathol 71: 582-585. (Pubitemid 9226873)
37. Borregaard N, Cross AR, Herlin T et al. (1983): A variant form of X-linked chronic granulomatous disease with normal nitroblue tetrazolium slide test and cytochrome b. Eur J Clin Ivest 13: 243-248.
38. Cheson BD, Christensen RL, Sperling R et al. (1976): The origin of the chemiluminescence of phagocytosing granulocytes. J Clin Invest 58: 789-796.
39. Mills EL, Rholl KS, Quie PG (1980): Luminol-amplified chemiluminescence: a sensitive method for detecting the carrier state in chronic granulomatous disease. Clin Microbiol 12: 52-56.
40. Emmendörffer A, Nakamura M, Rothe G et al. (1994): Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Cytometry 18: 147-155.
41. Jirapongsananuruk O, Malech HL, Kuhns DB et al. (2003): Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. Allergy Clin Imunol 111: 374-379.
42. Epling CL, Stites DP, McHugh TM et al. (1992): Neutrophil function screening in patients with chronic granulomatous disease by a flow cytometric method. Cytometry 13: 615-620.
43. Mauch L, Lun A, O'orman MR et al. (2007): Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. Clin Chem 53: 890-896.
44. Vowells SJ, Sekhsaria S, Malech HL et al. (1995): Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. Immunol Methods 178: 89-97.
45. Condino-Neto A, Muscara MN, Grumach AS et al. (1993): Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide. Br J Clin Pharmacol 35: 485-490. (Pubitemid 23158062)
46. Agudelo-Flórez P, López JA, Redher J et al. (2004): The use of reverse transcription-PCR for the diagnosis of X-linked chronic granulomatous disease. Braz J Med Biol Res 37: 625-634.
47. Ayatollahi M, Tabei Z, Ramzi M et al. (2006): A Fast and easy nitroblue tetrazolium method for carrier screening and prenatal detection of chronic granulomatous disease. Arch Iran Med 9: 335-338.
48. Matthay KK, Golbus MS, Wara DW, Mentzer WC (1984): Prenatal diagnosis of chronic granulomatous disease. Am J Med Genet 17: 731-739. (Pubitemid 14127532)
49. Huu TP, Dumez Y, Marquetty C et al. (1987): Prenatal diagnosis of chronic granulomatous disease (CGD) in four high risk male fetuses. Prenat Diagn 7: 253-260.
50. Chien S-C, Lee C-N, Hung C-C et al. (2003): Rapid prenatal diagnosis of X-linked chronic granulomatous disease using a denaturing high-performance liquid chromatography (DHPLC) system. Prenat Diagn 23: 1092-1096.
51. Lindlöf M, Kere J, Ristola M et al. (1987): Prenatal diagnosis of X-linked chronic granulomatous disease using restriction fragment length polymorphism analysis. Genomics 1: 87-92.
52. Kenney RT, Malech HL, Epstein ND et al. (1993): Characterization of the p67phox gene: genomic organization and restriction fragment length polymorphism analysis for prenatal diagnosis in chronic granulomatous disease. Blood 82: 3739-3744. (Pubitemid 2011396)
53. Cale CM, Jones AM, Goldblatt D (2000): Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin Exp Imuno 120: 351-355. (Pubitemid 30304233)
54. Wolach B, Scharf Y, Gavrieli R et al. (2005): Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a vovel mutation in CYBB. Blood 105: 61-66. (Pubitemid 40053064)
55. Khanna G, Kao SC, Kirby P, Sato Y (2005): Imaging of chronic granulomatous disease in children. Radio Graphics 25: 1183-1195.
56. Marciano BE, Rosenzweig SD, Kleiner DE et al. (2004): Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114: 462-468. (Pubitemid 39006676)
57. Lublin M, Bartlett DL, Danforth DN et al. (2002): Hepatic abscess in patients with chronic granulomatous disease. Ann Surg 235: 383-391. (Pubitemid 34183889)
58. Agus S, Spektor S, Israel Z (2000): CNS granulomatosis in child with chronic granulomatous disease. Br J Neuroserg 14: 59-61. (Pubitemid 30151007)
59. Tsugel I, Makimura K, Natsume J et al. (1998): Successful polymerase chain reaction-based diagnosis of fungal meningitis in a patient with chronic granulomatous disease. Acta Paediatr Jpn 40: 356-359. (Pubitemid 28366775)
60. Goldblatt D, Butcher J, Thrasher AJ, Russell-Eggitt I (1999): Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr 134: 780-783.
61. Pao N, Wiggs EA, Anastacio MM et al. (2004): Cognitive function in patients with chronic granulomatous disease: a preliminary report. Psychosomatic 45: 230-234. (Pubitemid 38621532)
62. Margolis DM, Melnick DA, Alling DW, Gallin JI (1990): Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 162: 723-726. (Pubitemid 20266166)
63. Tsuji S, Taniuchi S, Hasui M et al. (2002): Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole. Nitric Oxide 7: 283-288.
64. Gallin JI, Allong DW, Malech HL et al. (2003): Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 348: 2416-2422. (Pubitemid 36682820)
65. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group (1991): N Engl J Med 324: 509-516.
66. Sechler JM, Malech HL, White CJ, Gallin JI (1988): Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci USA 85: 4874-4878.
67. Ahlin A, Lärfars G, Elinder G et al. (1999): Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils. Clin Diagn Lab Immunol 6: 420-424. (Pubitemid 29226816)
68. Ezekowitz RA, Sieff CA, Dinauer MC et al. (1990): Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. Blood 76: 2443-2448.
69. Condino-Neto A, Newburqer PE (2000): Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon - responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood 95: 3548-3554. (Pubitemid 30428490)
70. Bemiller LS, Roberts DH, Starko KM, Curnutte JT (1995): Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease. Blood Cell Mol Dis 21: 239-247.
71. Marciano BE, Wesley R, De Carlo ES et al. (2004): Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39: 692-699. (Pubitemid 39180442)
72. Gerber CE, Bruchelt G, Falk UB et al. (2001): Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes. Blood 98: 3097-3105.
73. van't Hek LG, Verweij PE, Weemaes CM et al. (1998): Successful treatment with voriconazole of invasive Aspergillosis in chronic granulomatous disease. Am J Respir Crit Care Med 157: 1694-1696.
74. Walsh TJ, Lutsar I, Driscoll T et al. (2002): Voriconazole in the treatment of aspergillosis, scedoporiosis and other invasive fungal infection in children. Pediatr Infect Dis J 21: 240-248. (Pubitemid 34214142)
75. Sallmann S, Heilmann A, Heinke F et al. (2003): Caspofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease. Pediatr Infect Dis J 22: 199-200. (Pubitemid 36228142)
76. Rösen-Wolff A, Koch A, Friedrich W et al. (2004): Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease. Pediatr Infect Dis J 23: 584-586. (Pubitemid 38802312)
77. Segal BH, Barnhart LA, Anderson VL et al. (2005): Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 40: 1684-1688.
78. Ikincioqullari A, Dogu F, Solaz N et al. (2005): Granulocyte transfusion in children with chronic granulomatous disease and invasive aspergillosis. Ther Apher Dial 9: 137-141. (Pubitemid 40734775)
79. Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D et al. (2006): Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature. Ann Allergy Asthma Immunol 97: 257-261. (Pubitemid 44272596)
80. Narita M, Shibata M, Togashi T et al. (1991): Steroid therapy for bronchopneumonia in chronic granulomatous disease. Acta Paediatr Jpn 33: 181-185.
81. Rojo P, Ruiz-Contreras J, Gonzalez-Tome M et al. (2005): Outpatient treatment with corticosteroids and antibiotics for acalculous cholecystitis in chronic granulomatous disease. Acta Paediatr 94: 1684-1686. (Pubitemid 41754329)
82. Chin TW, Stiehm ER, Falloon J, Gallin JI (1987): Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr 111: 349-352.
83. Seger RA, Gungor T, Belohradsky BH et al. (2002): Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 100: 4344-4350. (Pubitemid 35429672)
84. Thrasher A, Goldblatt D (2001): Hematopoietic-cell transplantation for chronic granulomatous disease. N Engl J Med 345: 377-378. (Pubitemid 32703248)
85. Horwitz ME, Barrett AJ, Brown MR et al. (2001): Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 344: 881-888.
86. Horwitz M, Barrett A, Childs R et al. (1999): Nonmyeloablative, T-cell depleted allogeneic peripheral blood stem cell (PBSC) transplantation for patients with chronic granulomatous disease. Blood 94: 710a.
87. Ozsahin H, von Planta M, Müller I et al. (1998): Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor mobilized granulocytes, and liposomal amphotericin B. Blood 15: 2719-2724. (Pubitemid 28469084)
88. Dinauer M, Gifford M, Pech N et al. (2001): Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease. Blood 97: 3738-3745.
89. Ott MG, Segar R, Stein S et al. (2007): Advances in the treatment of chronic granulomatous disease by gene therapy. Curr Gene Ther 7: 155-161. (Pubitemid 46902198)
90. Sadat MA, Pech N, Saulnier S et al. (2003): Long- term high level reconstitution of NADPH oxidase activity in murine X-linked chronic granulomatous disease using a bicistronic vector expressing gp91phox and Delta LNGFR cell surface marker. Hum Gene Ther 1: 651-666. (Pubitemid 36543437)
91. Ott M, Schmidt M, Schwarzwaelder K et al. (2006): Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12: 401-409.
92. Roesler J, Koch A, Pörksen G et al. (2005): Benefit assessment of preventive medical check-ups in patients suffering from chronic granulomatous disease (CGD). J Eval Clin Pract 11: 513-521. (Pubitemid 41789733)
93. Foster CB, Lehrnbecher T, Mol F et al. (1998): Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 102: 2146-2155.
94. Arkwright PD, Abinun M, Cant AJ (2002): Autoimmunity in human primary immunodeficiency diseases. Blood 99: 2694-2702. (Pubitemid 34525354)
95. Siddiqui S, Anderson VL, Hilligoss DM (2007): Fulminant mulch pneumonititis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis 45: 673-681. (Pubitemid 47378879)
96. Villanacci V, Falchetti D, Liserre B et al. (2007): Diversion of the fecal stream resolves ulcerative colitis complicating chronic granulomatous disease in an adult patient. J Clin Gastroenterol 41: 491-493. (Pubitemid 46642537)
97. De Ravin SS, Naumann N, Robinson MR et al. (2006): Sarcoidosis in chronic granulomatous disease. Pediatrics 117: e590-e595.
98. Lee BW, Yap HK (1994): Polyarthritis resembling juvenile rheumatoid in a girl with chronic granulomatous disease. Arthritis Rheum 5: 773-776.
99. Manzi S, Urbach AH, McCune AB et al. (1991): Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review the literature. Arthritis Rheum 34: 101-105.
100. Schumacher RF, Arrighini A, AlbertiD et al. (1998): Ureteral obstruction in a patient with chronic granulomatous disease, receiving combined prophylaxis with IFN-gamma and antibiotics Eur J Pediatr 157: 352-353.
101. Chalumeau M, Monnet D, Brézin AP et al. (2007): Chorioretinal lesions as the unique feature of complete chronic granulomatous disease in an 8-year-old girl. Eur J Pediatr 166: 1069-1070. (Pubitemid 47313055)
102. Charon JA, Mergenhagen SE, Gallin JI (1985): Gingivitis and oral ulceration in patients with neutrophil dysfunction. J Oral Pathol 14: 150-155.
103. Dusi S, Poli G, Berton G et al. (1990): Chronic granulomatous disease in an adult female with granulomatous cheilitis. Evidence for an X-linked pattern of inheritance with extreme lyonization. Acta Haematol 84: 49-56.
104. Garratty G, Sattler MS, Petz LD, Flannery EP (1979): Immune hemolytic anemia assotited with anti-Kell and a carrier state for chronic granulomatous disease. Rev Fr Transfus Immunohematol 22: 529-549.
105. Vieira AP, Vasconcelos J, Fernandes JC et al. (2004): Lymphadenopathy after BCG vaccination in a child with chronic granulomatous disease. Pediatr Dermatol 21: 646-651. (Pubitemid 39657387)